Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population (Q39153165)
Jump to navigation
Jump to search
scientific article published on 15 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population |
scientific article published on 15 May 2014 |
Statements
1 reference
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population (English)
1 reference
Eugene Braunwald
1 reference
Robert M Califf
1 reference
Christopher P Cannon
1 reference
Michael A Blazing
1 reference
Amy McCagg
1 reference
Craig Reist
1 reference
Andrew M Tershakovec
1 reference
Thomas A Musliner
1 reference
Jennifer A White
1 reference
15 May 2014
1 reference
1 reference
Identifiers
1 reference